Summary:
This is a randomized, double-blind, placebo-controlled study to determine if sodium bicarobnate and menthol in a topical transdermal delivery lotion (DYV700) effectively and safely reduces pain associated with an acute gout flare.
Qualified Participants Must:
• Be between 18-75 years of age
•
Have at least 2 gout flares within the last year
Qualified Participants May Receive:
- Compensation for time and travel expenses
- Study related care such as blood work and EKG
- Physical performed by a board certified physician